Cargando…
Tumor-related molecular determinants of neurocognitive deficits in patients with diffuse glioma
BACKGROUND: Cognitive impairment is a common and debilitating symptom in patients with diffuse glioma, and is the result of multiple factors. We hypothesized that molecular tumor characteristics influence neurocognitive functioning (NCF), and aimed to identify tumor-related markers of NCF in diffuse...
Autores principales: | van Kessel, Emma, Berendsen, Sharon, Baumfalk, Anniek E, Venugopal, Hema, Krijnen, Eva A, Spliet, Wim G M, van Hecke, Wim, Giuliani, Fabrizio, Seute, Tatjana, van Zandvoort, Martine J E, Snijders, Tom J, Robe, Pierre A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527514/ https://www.ncbi.nlm.nih.gov/pubmed/35148403 http://dx.doi.org/10.1093/neuonc/noac036 |
Ejemplares similares
-
Effects of valproic acid on histone deacetylase inhibition in vitro and in glioblastoma patient samples
por: Berendsen, Sharon, et al.
Publicado: (2019) -
Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a systematic review of neurocognitive functioning prior to anti-tumor treatment
por: van Kessel, Emma, et al.
Publicado: (2017) -
Neurocognitive changes after awake surgery in glioma patients: a retrospective cohort study
por: van Kessel, Emma, et al.
Publicado: (2019) -
Epilepsy Associates with Decreased HIF-1α/STAT5b Signaling in Glioblastoma
por: Berendsen, Sharon, et al.
Publicado: (2019) -
Early Surgery Prolongs Professional Activity in IDH Mutant Low-Grade Glioma Patients: A Policy Change Analysis
por: Robe, Pierre A., et al.
Publicado: (2022)